The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...

The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...

Pfizer exec Philip Dormitzer amid claims the COVID-19 vaccine announcement was delayed to avoid influencing the 2020 election ...

The House Judiciary Committee subpoenaed a former Pfizer executive who allegedly claimed senior members of the company ...

A former Pfizer scientist was subpoenaed Monday by House Republicans over allegations that senior executives at the pharma ...

The panel makes recommendations on use of vaccines in the United States. At least three of the new members have spoken out against mRNA COVID-19 vaccines.

The mNexspike vaccine is supplied as a single-dose prefilled syringe containing 1 dose of 0.2mL. The single 0.2mL dose should be administered at least 3 months after the last dose of COVID-19 vaccine.

Citing COVID-19 vaccine recommendations from other high-income countries — none of which has a universal recommendation — along with what they described as uncertainty about whether healthy ...

The approval was supported by data from the phase 3 NextCOVE study (NCT05815498), which was designed to compare mNexspike to Moderna’s bivalent COVID-19 vaccine (original and omicron BA.4/BA.5).